<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mourikis TP</submitter><funding>Cancer Research UK</funding><funding>Medical Research Council</funding><funding>The Francis Crick Institute</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>3101</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6629660</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>The identification of cancer-promoting genetic alterations is challenging particularly in highly unstable and heterogeneous cancers, such as esophageal adenocarcinoma (EAC). Here we describe a machine learning algorithm to identify cancer genes in individual patients considering all types of damaging alterations simultaneously. Analysing 261 EACs from the OCCAMS Consortium, we discover helper genes that, alongside well-known drivers, promote cancer. We confirm the robustness of our approach in 107 additional EACs. Unlike recurrent alterations of known drivers, these cancer helper genes are rare or patient-specific. However, they converge towards perturbations of well-known cancer processes. Recurrence of the same process perturbations, rather than individual genes, divides EACs into six cl</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.</pubmed_title><pmcid>PMC6629660</pmcid><funding_grant_id>10008</funding_grant_id><funding_grant_id>23923</funding_grant_id><funding_grant_id>23924</funding_grant_id><funding_grant_id>MC_PC_16048</funding_grant_id><funding_grant_id>1786366</funding_grant_id><funding_grant_id>MR/L001411/1</funding_grant_id><funding_grant_id>10152</funding_grant_id><funding_grant_id>S_3659</funding_grant_id><funding_grant_id>16463</funding_grant_id><funding_grant_id>25487</funding_grant_id><funding_grant_id>20406</funding_grant_id><funding_grant_id>C43634/A25487</funding_grant_id><pubmed_authors>Davies A</pubmed_authors><pubmed_authors>Lynch AG</pubmed_authors><pubmed_authors>de la Rue R</pubmed_authors><pubmed_authors>Cereda M</pubmed_authors><pubmed_authors>Contino G</pubmed_authors><pubmed_authors>Lovat L</pubmed_authors><pubmed_authors>Yau C</pubmed_authors><pubmed_authors>Robert O'Neill J</pubmed_authors><pubmed_authors>Hughes C</pubmed_authors><pubmed_authors>Taniere P</pubmed_authors><pubmed_authors>Lishman S</pubmed_authors><pubmed_authors>Mahadeva U</pubmed_authors><pubmed_authors>Sujendran V</pubmed_authors><pubmed_authors>Cheong E</pubmed_authors><pubmed_authors>Sanders G</pubmed_authors><pubmed_authors>Grehan N</pubmed_authors><pubmed_authors>Walker RC</pubmed_authors><pubmed_authors>Davies J</pubmed_authors><pubmed_authors>Kaye P</pubmed_authors><pubmed_authors>O'Donovan M</pubmed_authors><pubmed_authors>Fitzgerald RC</pubmed_authors><pubmed_authors>Bornschein J</pubmed_authors><pubmed_authors>Oakes S</pubmed_authors><pubmed_authors>Igali L</pubmed_authors><pubmed_authors>Peters CJ</pubmed_authors><pubmed_authors>Jammula S</pubmed_authors><pubmed_authors>Fickling W</pubmed_authors><pubmed_authors>Hayes SJ</pubmed_authors><pubmed_authors>Moorthy K</pubmed_authors><pubmed_authors>MacRae S</pubmed_authors><pubmed_authors>Secrier M</pubmed_authors><pubmed_authors>Elliott RF</pubmed_authors><pubmed_authors>Crichton C</pubmed_authors><pubmed_authors>Puig S</pubmed_authors><pubmed_authors>Hupp TR</pubmed_authors><pubmed_authors>Shepherd N</pubmed_authors><pubmed_authors>Benedetti L</pubmed_authors><pubmed_authors>Parsons SL</pubmed_authors><pubmed_authors>Chang F</pubmed_authors><pubmed_authors>Katz-Summercorn A</pubmed_authors><pubmed_authors>Crawte J</pubmed_authors><pubmed_authors>Miremadi A</pubmed_authors><pubmed_authors>Temelkovski D</pubmed_authors><pubmed_authors>Barr H</pubmed_authors><pubmed_authors>Preston SR</pubmed_authors><pubmed_authors>Ciccarelli FD</pubmed_authors><pubmed_authors>Edwards PAW</pubmed_authors><pubmed_authors>Turkington R</pubmed_authors><pubmed_authors>Foxall E</pubmed_authors><pubmed_authors>Safranek P</pubmed_authors><pubmed_authors>Carroll N</pubmed_authors><pubmed_authors>Lagergren J</pubmed_authors><pubmed_authors>Goh V</pubmed_authors><pubmed_authors>Saunders J</pubmed_authors><pubmed_authors>Hanna GB</pubmed_authors><pubmed_authors>Howell M</pubmed_authors><pubmed_authors>Tavare S</pubmed_authors><pubmed_authors>Noorani A</pubmed_authors><pubmed_authors>Save V</pubmed_authors><pubmed_authors>Lewis M</pubmed_authors><pubmed_authors>Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium</pubmed_authors><pubmed_authors>Devonshire G</pubmed_authors><pubmed_authors>Nutzinger B</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>McManus D</pubmed_authors><pubmed_authors>Ang Y</pubmed_authors><pubmed_authors>Loureda D</pubmed_authors><pubmed_authors>Grabowska A</pubmed_authors><pubmed_authors>Malhotra S</pubmed_authors><pubmed_authors>Mourikis TP</pubmed_authors><pubmed_authors>Bower L</pubmed_authors><pubmed_authors>Hindmarsh A</pubmed_authors><pubmed_authors>Scott M</pubmed_authors><pubmed_authors>Fidziukiewicz E</pubmed_authors><pubmed_authors>Sothi S</pubmed_authors><pubmed_authors>Gossage J</pubmed_authors><pubmed_authors>Perner J</pubmed_authors><pubmed_authors>Scaffidi P</pubmed_authors><pubmed_authors>Zylstra J</pubmed_authors><pubmed_authors>Haidry R</pubmed_authors><pubmed_authors>Suortamo S</pubmed_authors><pubmed_authors>Harden C</pubmed_authors><pubmed_authors>Skipworth RJE</pubmed_authors><pubmed_authors>Beggs A</pubmed_authors><pubmed_authors>Underwood TJ</pubmed_authors><pubmed_authors>Bagwan I</pubmed_authors><pubmed_authors>Abbas S</pubmed_authors><pubmed_authors>Nulsen J</pubmed_authors><pubmed_authors>Berrisford R</pubmed_authors><pubmed_authors>Tripathi M</pubmed_authors><pubmed_authors>Khoo D</pubmed_authors><pubmed_authors>Sharrocks A</pubmed_authors><pubmed_authors>Grace BL</pubmed_authors><pubmed_authors>Soomro I</pubmed_authors><pubmed_authors>Northrop A</pubmed_authors><pubmed_authors>Tucker O</pubmed_authors><pubmed_authors>Old O</pubmed_authors><pubmed_authors>Kumar B</pubmed_authors><pubmed_authors>Eldridge M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.</name><description>The identification of cancer-promoting genetic alterations is challenging particularly in highly unstable and heterogeneous cancers, such as esophageal adenocarcinoma (EAC). Here we describe a machine learning algorithm to identify cancer genes in individual patients considering all types of damaging alterations simultaneously. Analysing 261 EACs from the OCCAMS Consortium, we discover helper genes that, alongside well-known drivers, promote cancer. We confirm the robustness of our approach in 107 additional EACs. Unlike recurrent alterations of known drivers, these cancer helper genes are rare or patient-specific. However, they converge towards perturbations of well-known cancer processes. Recurrence of the same process perturbations, rather than individual genes, divides EACs into six cl</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2026-05-06T21:56:17.78Z</modification><creation>2019-07-25T07:10:08Z</creation></dates><accession>S-EPMC6629660</accession><cross_references><pubmed>31308377</pubmed><doi>10.1038/s41467-019-10898-3</doi></cross_references></HashMap>